Weiqiang Lin

3.7k total citations
89 papers, 2.4k citations indexed

About

Weiqiang Lin is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Weiqiang Lin has authored 89 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 20 papers in Nephrology and 14 papers in Cancer Research. Recurrent topics in Weiqiang Lin's work include Acute Kidney Injury Research (9 papers), MicroRNA in disease regulation (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Weiqiang Lin is often cited by papers focused on Acute Kidney Injury Research (9 papers), MicroRNA in disease regulation (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Weiqiang Lin collaborates with scholars based in China, United States and United Kingdom. Weiqiang Lin's co-authors include Tianfeng Chen, Jianghua Chen, Fei Han, Yunjing Zhang, Hongwu Bian, Muyuan Zhu, Xianghui Fu, Hongxing Liu, Junhui Wang and Ning Han and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and PLoS ONE.

In The Last Decade

Weiqiang Lin

86 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiqiang Lin China 30 1.2k 347 320 284 284 89 2.4k
Fei Liao China 28 1.3k 1.1× 240 0.7× 173 0.5× 240 0.8× 246 0.9× 211 2.7k
Alexei G. Basnakian United States 31 1.5k 1.2× 221 0.6× 266 0.8× 362 1.3× 126 0.4× 80 3.1k
Xianyin Lai United States 24 815 0.7× 289 0.8× 229 0.7× 82 0.3× 203 0.7× 66 2.1k
Qiuping Liu China 28 1.4k 1.2× 597 1.7× 428 1.3× 84 0.3× 188 0.7× 107 3.4k
Pingping Ren China 26 787 0.7× 156 0.4× 147 0.5× 173 0.6× 120 0.4× 73 2.2k
Xi Zhou China 30 2.1k 1.8× 612 1.8× 159 0.5× 81 0.3× 157 0.6× 112 3.6k
Yingying Zhang China 20 2.3k 1.9× 386 1.1× 214 0.7× 112 0.4× 114 0.4× 69 3.1k
Dianwen Ju China 37 1.9k 1.6× 391 1.1× 347 1.1× 150 0.5× 83 0.3× 146 4.0k
Ting Chen China 34 1.5k 1.2× 694 2.0× 107 0.3× 167 0.6× 142 0.5× 137 2.9k
Ningning Wang China 31 2.3k 1.9× 578 1.7× 407 1.3× 59 0.2× 217 0.8× 122 3.2k

Countries citing papers authored by Weiqiang Lin

Since Specialization
Citations

This map shows the geographic impact of Weiqiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiang Lin more than expected).

Fields of papers citing papers by Weiqiang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiang Lin. The network helps show where Weiqiang Lin may publish in the future.

Co-authorship network of co-authors of Weiqiang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqiang Lin. A scholar is included among the top collaborators of Weiqiang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqiang Lin. Weiqiang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shi, Chengyu, Ying Wang, Linyu Zhu, et al.. (2024). HMPA: a pioneering framework for the noncanonical peptidome from discovery to functional insights. Briefings in Bioinformatics. 25(6).
3.
Lin, Weiqiang, Chenguang Shen, Mengjun Li, et al.. (2024). Programmable Macrophage Vesicle Based Bionic Self‐Adjuvanting Vaccine for Immunization against Monkeypox Virus. Advanced Science. 12(1). e2408608–e2408608. 36 indexed citations
4.
Zhang, Wei, Lei Bai, Wentao Xu, et al.. (2024). Sirt6 Mono‐ADP‐Ribosylates YY1 to Promote Dystrophin Expression for Neuromuscular Transmission. Advanced Science. 11(44). e2406390–e2406390. 4 indexed citations
5.
Lin, Weiqiang, Jianyu Wu, Liwen Cao, et al.. (2024). Transcriptomic Insights into Metabolism-Dependent Biosynthesis of Bacterial Nanocellulose. ACS Applied Bio Materials. 7(3). 1801–1809.
6.
Wang, Junni, Huijing Wang, Xiaohan Huang, et al.. (2024). SNORD3A Regulates STING Transcription to Promote Ferroptosis in Acute Kidney Injury. Advanced Science. 11(33). e2400305–e2400305. 16 indexed citations
7.
Zou, Sailan, Guixiang Zhang, Meilin Ma, et al.. (2023). Extrachromosomal circular MiR-17-92 amplicon promotes HCC. Hepatology. 79(1). 79–95. 37 indexed citations
8.
Wang, Hongju, Lingling Shi, Longlong Wu, et al.. (2023). STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury. Free Radical Biology and Medicine. 208. 348–360. 64 indexed citations
9.
Yao, Xi, Yi Zhang, Gensheng Zhang, et al.. (2023). TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy. Theranostics. 13(13). 4356–4375. 33 indexed citations
11.
Zhang, Yunjing, Jicheng Wu, Quanlin An, et al.. (2023). Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD. Nano Research. 16(7). 9701–9714. 4 indexed citations
12.
Weng, Chunhua, Haojie Dong, Rongpan Bai, et al.. (2022). Angiogenin promotes angiogenesis via the endonucleolytic decay of miR-141 in colorectal cancer. Molecular Therapy — Nucleic Acids. 27. 1010–1022. 12 indexed citations
13.
Li, Mobai, Boqiang Liu, Ying Zhang, et al.. (2022). A circular RNA, circPTPN14, increases MYC transcription by interacting with FUBP1 and exacerbates renal fibrosis. Cellular and Molecular Life Sciences. 79(12). 595–595. 6 indexed citations
14.
Lin, Weiqiang, Jiadong Ji, Mingzhuo Li, et al.. (2020). PMINR: Pointwise Mutual Information-Based Network Regression – With Application to Studies of Lung Cancer and Alzheimer’s Disease. Frontiers in Genetics. 11. 556259–556259. 6 indexed citations
15.
Guo, Xingyi, Zhishan Chen, Yumin Xia, Weiqiang Lin, & Hongzhi Li. (2020). Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Journal of Translational Medicine. 18(1). 321–321. 34 indexed citations
16.
Zheng, Lan, et al.. (2019). Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy. Biomaterials. 216. 119220–119220. 103 indexed citations
17.
Hong, Xuwei, Hong Huang, Yuanfeng Zhang, et al.. (2018). The Effect of Daily Fluid Management and Beverages Consumption on the Risk of Bladder Cancer: A Meta-analysis of Observational Study. Nutrition and Cancer. 70(8). 1217–1227. 11 indexed citations
18.
Guo, Xingyi, Weiqiang Lin, Jiandong Bao, et al.. (2018). A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies. The American Journal of Human Genetics. 102(5). 890–903. 56 indexed citations
19.
Yuan, Yuan, et al.. (2018). 应用动物模型探索肾脏疾病作用机制和潜在治疗靶点. 动物学研究. 39(2). 72–86. 112 indexed citations
20.
Lin, Weiqiang, et al.. (2011). Scc2 regulates gene expression by recruiting cohesin to the chromosome as a transcriptional activator during yeast meiosis. Molecular Biology of the Cell. 22(12). 1985–1996. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026